- Home
- NUWE vs LEO Comparison
NUWE vs LEO Comparison
Compare NUWE & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUWE | LEO |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | 38 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 399.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NUWE | LEO |
|---|---|---|
| Price | $1.08 | $6.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 63.3K | ★ 153.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | N/A |
| Revenue This Year | $11.14 | N/A |
| Revenue Next Year | $18.51 | N/A |
| P/E Ratio | ★ N/A | $157.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $5.67 |
| 52 Week High | $25.95 | $6.55 |
Technical Indicators
Market Signals| Indicator | NUWE | LEO |
|---|---|---|
| Relative Strength Index (RSI) | 31.12 | 41.07 |
| Support Level | $0.20 | $6.20 |
| Resistance Level | $2.86 | $6.37 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 3.14 | 27.59 |
Price Performance
Historical ComparisonAbout NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products include equity and fixed income mutual funds, retail money market funds, government/treasury money market funds, institutional money market funds, and others. The company and its affiliates, as well as others involved in the management, sales, investment activities, business operations, or distribution of the fund, are engaged in businesses and have interests other than those of managing the fund.